KOJIN TX
Live / Registered — Registered (as of 04 Feb 2025)
What this means for you
Registered since 04 Feb 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Feb 2031: the §8 declaration of use).
Record
- Serial number
- 98528844
- Registration number
- 7678137
- Mark type
- Stylized text
- Filed
- 01 May 2024
- Published for opposition
- 17 Dec 2024
- Registered
- 04 Feb 2025
- Next maintenance filing
- §8 declaration of use, due by 04 Feb 2031 (grace period to 04 Aug 2031)
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 042 — Scientific and technological services: research and development of pharmaceutical preparations for the treatment of cancer, asthma and inflammatory diseases, autoimmune diseases, cardiovascular diseases, liver diseases, degenerative diseases, infectious diseases, allergies, central nervous system diseases, and renal diseases; providing scientific research information in the field of pharmaceutical preparations for the treatment of cancer, asthma and inflammatory diseases, autoimmune diseases, cardiovascular diseases, liver diseases, degenerative diseases, infectious diseases, allergies, central nervous system diseases, and renal diseases
Owner
- Kojin Therapeutics, Inc., Boston, MA, US
- Kojin Therapeutics, Inc., Boston, MA, US
- Kojin Therapeutics, Inc., Boston, MA, US
Prosecution history
- 04 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION
- 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Nov 2024 — EXAMINER'S AMENDMENT ENTERED
- 20 Nov 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 20 Nov 2024 — EXAMINERS AMENDMENT E-MAILED
- 20 Nov 2024 — EXAMINERS AMENDMENT -WRITTEN
- 15 Nov 2024 — ASSIGNED TO EXAMINER
- 27 Oct 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 May 2024 — NEW APPLICATION ENTERED